Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aequus Pharmaceuticals Inc (AQS.VN)

Aequus Pharmaceuticals Inc (AQS.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,284
  • Shares Outstanding, K 132,634
  • Annual Sales, $ 2,593 K
  • Annual Income, $ -1,045 K
  • 60-Month Beta 0.42
  • Price/Sales 3.19
  • Price/Cash Flow N/A
  • Price/Book 4.44
Trade AQS.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings 0.00 on N/A
  • Next Earnings Date 05/30/22
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.065 +7.69%
on 05/06/22
0.080 -12.50%
on 04/20/22
-0.005 (-6.67%)
since 04/08/22
3-Month
0.065 +7.69%
on 05/06/22
0.095 -26.32%
on 03/22/22
-0.020 (-22.22%)
since 02/09/22
52-Week
0.065 +7.69%
on 05/06/22
0.170 -58.82%
on 05/10/21
-0.105 (-60.00%)
since 05/07/21

Most Recent Stories

More News
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Announces Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Announces Short Term Loan

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Announces Director Resignation

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medication

Health Canada Submission of Preservative-Free Prescription ‘Zimed PF’ Accepted for Screening VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE)...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be...

AKR.VN : 0.080 (+14.29%)
AKRFF : 0.0643 (-14.83%)
ADCO.TO : 0.2700 (unch)
ADCOF : 0.2145 (+2.14%)
ACT.CN : 0.500 (-10.71%)
ACTHF : 0.4000 (-7.11%)
ACOG.VN : 0.700 (+1.45%)
ACOGF : 0.5549 (+0.89%)
ALY.VN : 0.470 (+9.30%)
ATIXF : 0.2910 (+18.10%)
AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Reports Third Quarter 2021 Financial Highlights

Second Largest Revenue Quarter in Company History and New Evolve Product Sales Double...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Reports Second Quarter 2021 Financial Highlights

Second Highest Quarterly Revenues in Company History

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Aequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertise

VANCOUVER, British Columbia, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus”) a speciality pharmaceutical company, is pleased to announce that...

AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.070
2nd Resistance Point 0.070
1st Resistance Point 0.070
Last Price 0.070
1st Support Level 0.070
2nd Support Level 0.070
3rd Support Level 0.070

See More

52-Week High 0.170
Fibonacci 61.8% 0.130
Fibonacci 50% 0.117
Fibonacci 38.2% 0.105
Last Price 0.070
52-Week Low 0.065

See More

Business Summary

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar